Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy (Q33565604)

28 July 2017

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy (English)

1 reference

28 July 2017

1 reference

1 reference

1

Paul E Sax

1 reference

28 July 2017

15

Susan L Koletar

1 reference

28 July 2017

3

Ann C Collier

1 reference

28 July 2017

4

Margaret A Fischl

1 reference

28 July 2017

18

Eric S Daar

1 reference

28 July 2017

Camlin Tierney

2

1 reference

28 July 2017

Katie Mollan

5

1 reference

28 July 2017

Lynne Peeples

6

1 reference

28 July 2017

Catherine Godfrey

7

1 reference

28 July 2017

Nasreen C Jahed

8

1 reference

28 July 2017

Laurie Myers

9

1 reference

28 July 2017

David Katzenstein

10

1 reference

28 July 2017

Awny Farajallah

11

1 reference

28 July 2017

James F Rooney

12

1 reference

28 July 2017

Belinda Ha

13

1 reference

28 July 2017

William C Woodward

14

1 reference

28 July 2017

Victoria A Johnson

16

1 reference

28 July 2017

P Jan Geiseler

17

1 reference

28 July 2017

AIDS Clinical Trials Group Study A5202 Team

19

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

The New England Journal of Medicine

28 July 2017

1 reference

28 July 2017

361

1 reference

28 July 2017

23

1 reference

28 July 2017

2230-2240

1 reference

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Broad Nucleoside Reverse‐Transcriptase Inhibitor Cross‐Resistance in Human Immunodeficiency Virus Type 1 Clinical Isolates

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2800041

Update of the drug resistance mutations in HIV-1: Spring 2008

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19952143

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA0906768

1 reference

release_mpqv2lgvljhdzfr6inwn3454tu

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mpqv2lgvljhdzfr6inwn3454tu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

2800041

1 reference

28 July 2017

1 reference